Hillhouse Fund IV, L.P. - Net Worth and Insider Trading

Hillhouse Fund IV, L.P. Net Worth

The estimated net worth of Hillhouse Fund IV, L.P. is at least $208 Million dollars as of 2024-09-27. Hillhouse Fund IV, L.P. is the 2201 Interest of corporation controlled by you of Genor Biopharma Holdings Ltd and owns about 126,239,103 shares of Genor Biopharma Holdings Ltd (HKSE:06998) stock worth over $208 Million. Details can be seen in Hillhouse Fund IV, L.P.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Hillhouse Fund IV, L.P. has not made any transactions after 2022-10-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Hillhouse Fund IV, L.P.

Hillhouse Fund IV, L.P. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hillhouse Fund IV, L.P. owns 1 companies in total, including Genor Biopharma Holdings Ltd (HKSE:06998) .

Click here to see the complete history of Hillhouse Fund IV, L.P.’s form 4 insider trades.

Insider Ownership Summary of Hillhouse Fund IV, L.P.

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:06998	Genor Biopharma Holdings Ltd	2022-10-20	2201 Interest of corporation controlled by you

Hillhouse Fund IV, L.P. Latest Holdings Summary

Hillhouse Fund IV, L.P. currently owns a total of 1 stock. Hillhouse Fund IV, L.P. owns 126,239,103 shares of Genor Biopharma Holdings Ltd (HKSE:06998) as of October 20, 2022, with a value of $208 Million.

Latest Holdings of Hillhouse Fund IV, L.P.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06998	Genor Biopharma Holdings Ltd	2022-10-20	126,239,103	1.65	208,294,520

Holding Weightings of Hillhouse Fund IV, L.P.

Hillhouse Fund IV, L.P. Form 4 Trading Tracker

According to the SEC Form 4 filings, Hillhouse Fund IV, L.P. has made a total of 4 transactions in Genor Biopharma Holdings Ltd (HKSE:06998) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Genor Biopharma Holdings Ltd is the sale of 0 shares on October 20, 2022, which brought Hillhouse Fund IV, L.P. around $0.

Insider Trading History of Hillhouse Fund IV, L.P.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hillhouse Fund IV, L.P. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Hillhouse Fund IV, L.P. Ownership Network

Ownership Network List of Hillhouse Fund IV, L.P.

No Data

Ownership Network Relation of Hillhouse Fund IV, L.P.

Hillhouse Fund IV, L.P. Owned Company Details

What does Genor Biopharma Holdings Ltd do?

Who are the key executives at Genor Biopharma Holdings Ltd?

Hillhouse Fund IV, L.P. is the 2201 Interest of corporation controlled by you of Genor Biopharma Holdings Ltd. Other key executives at Genor Biopharma Holdings Ltd include 2102 Investment manager Hillhouse Investment Management, Ltd. , 2101 Beneficial owner Hhjh Holdings Limited , and 2201 Interest of corporation controlled by you HH BIO Investment Fund, L.P. .

Genor Biopharma Holdings Ltd (HKSE:06998) Insider Trades Summary

Over the past 18 months, Hillhouse Fund IV, L.P. made no insider transaction in Genor Biopharma Holdings Ltd (HKSE:06998). Other recent insider transactions involving Genor Biopharma Holdings Ltd (HKSE:06998) include a net sale of 0 shares made by Hillhouse Investment Management, Ltd. ,

In summary, during the past 3 months, insiders sold 0 shares of Genor Biopharma Holdings Ltd (HKSE:06998) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genor Biopharma Holdings Ltd (HKSE:06998) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genor Biopharma Holdings Ltd (HKSE:06998)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genor Biopharma Holdings Ltd Insider Transactions

No Available Data

Hillhouse Fund IV, L.P. Mailing Address

Above is the net worth, insider trading, and ownership report for Hillhouse Fund IV, L.P.. Currently GuruFocus does not have mailing address information for Hillhouse Fund IV, L.P..

Discussions on Hillhouse Fund IV, L.P.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.